결핵성 파괴폐의 수술적 치료에 대한 술후 이환율과 사망률에 영향을 미치는 위험 인자에 대한 임상고찰

Clinical Evaluation of Risk Factors Affection Postoperative Morbidity and Mortality in the Surgical Treatment of Tuberculous Destroyed Lung

  • 신성호 (한양대학교병원 흉부외과학교실) ;
  • 정원상 (한양대학교병원 흉부외과학교실) ;
  • 지행옥 (한양대학교병원 흉부외과학교실) ;
  • 강정호 (한양대학교병원 흉부외과학교실) ;
  • 김영학 (한양대학교병원 흉부외과학교실) ;
  • 김혁 (한양대학교병원 흉부외과학교실)
  • Shin, Sung-Ho (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Hospital) ;
  • Chung, Won-Sang (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Hospital) ;
  • Jee, Heng-Ok (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Hospital) ;
  • Kang, Jung-Ho (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Hospital) ;
  • Kim, Young-Hak (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Hospital) ;
  • Kim, Hyuck (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Hanyang University Hospital)
  • 발행 : 2000.03.01

초록

Background: This retrospective study tries to identify specific risk factors that may increase complication rates after the surgical treatment of tuberculous destroyed lung. Material and method: A retrospective study was performed on forty-seven patients, who received surgical treatment for tuberculous destroyed lung in the Department of Thoracic and Cardiovascular Surgery at Hanyang University Hospital from 1988 to 1998, to identify specific preoperative risk factors related to postoperative complications. Fisher's exact test was used to identify the correlations between the complications and right pneumonectomy, preoperative FEV1, predicted postoperative FEV1, massive hemoptysis, postoperative persistent empyema. Result: Hospital mortality and morbidity rates of the patients who received surgical treatment for tuberculous destroyed lung were 6.4% and 29.7%, respectively. In view of the hospital mortality and morbidity rates as a whole, predicted postoperative FEV1 less than 0.8L(p<0.005), preoperative FEV1 less than 1.8L(p=0.01), massive hemoptysis(p<0.005), postoperative persistent positive sputum cultures(p<0.0005), and the presence of multi drug resistant tuberculosis(p<0.05) presented statistically significant correlations. Among the postoperative complications, bronchopleural fistula, the most common complication, was found to have statistically significant corrleations with the preoperative empyema(p<0.05) and postoperative persistent positive sputum cultures(p<0.05). Conclusion: Although mortality and morbidity rates after surgical treatment of tuberculous destroyed lung were relatively low, when predicted postoperative FEV1 was less than 0.8L, when preoperative FEV1 was less than 1.8L, when massive hemoptysis was present, when postoperative sputum cultures were persistently positive, and when multi drug resistant tuberculosis was present, the rates were significantly higher.

키워드

참고문헌

  1. 전국 결핵 실태조사 보고서 보건사회부;대한결핵협회
  2. 대흉외지 v.25 폐결핵의 폐절제술 후 객담 균양성환자에 대한 임상고찰 심성보;김욱진;김병석;장동철;김범식
  3. 대흉외지 v.28 전폐절제술에 있어서 수술위험인자의 평가 정경영;김길동
  4. Ann Thorac Surg v.64 Factors affecting postoperative morbidity and mortality in destroyed lung Halezeroglu S.;Keles M.;Yusal A.(et al.)
  5. The left bronchus syndrome;Thorax v.45 Unilateral posttuberculous lung destruction Ashour M.;Pandya L.;Mezraqji A.(et al.)
  6. Chest Surg Clin North Am. v.4 Surgery for tuberculosis Pomerantz M.
  7. Ann Thorac Surg v.61 Prospective analysis of pneumonectomy: risk factors for major morbidity and cardiac dysarrhythmias Halpole DH Jr.;Liptay MJ;DeCamp MM Jr.;Mentzer SJ;Swanson SJ;Sugarbakei DJ
  8. Acta Chir Scand v.111 Indication for and result of thoracic surgery with regard to repiratory and circulatory function test Uggla IG
  9. Respir v.30 Lung function test results and the risk of post-thoracotomy complication Lockwood P
  10. 대흉외지 v.27 객혈환자의 임상적 고찰 김호경;오중환;이종국(등)
  11. 대흉외지 v.28 각혈환자의 폐절제술 박병률;김병철;이용훈;양석승;이종수;정수상
  12. World J Surg v.21 Surgical indication for treatment of pulmonary tuberculosis Freixinet J
  13. 대흉외지 v.30 폐결핵 환자에 적용된 폐절제술의 임상적 연구 전희재;한동기;박승규;송선대;최필조;우종수
  14. Ann Thorac Surg v.52 Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infection Pomerantz M;Madsen L;Goble M;Iscman M
  15. Curr Probl Surg v.23 no.6 Suppurative disease of the lung and pleural space;Part I. Empyema thoracis and lung abscess LeRoux BT
  16. Parapneumonic effusion and infection of the pleural space in pleural diseases Light RW;RW Light
  17. 대흉외지 v.26 전폐절제술후 발생한 합병증에 대한 분석 허강배;조성래;김수현(등)
  18. J Thorac Cardiovasc Surg v.62 Management of Persistent bronchopleural fistula Barker WL;Osteimiller WE;Langston HT
  19. J Thorac Cardiovasc Surg v.45 A procedure for the management of postpneunonectomy empyema Clagett OT;Geraci JE